nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—ADK—Purine metabolism—ADSL—atopic dermatitis	0.0209	0.152	CbGpPWpGaD
Vidarabine—ADA—Purine metabolism—ADSL—atopic dermatitis	0.0142	0.103	CbGpPWpGaD
Vidarabine—Glucosamine—IFNG—atopic dermatitis	0.0137	0.705	CrCbGaD
Vidarabine—ADORA2A—Activation of TRKA receptors—NGF—atopic dermatitis	0.0116	0.0843	CbGpPWpGaD
Vidarabine—ADK—Nucleotide metabolism—ADSL—atopic dermatitis	0.0105	0.0764	CbGpPWpGaD
Vidarabine—ADA—Nucleotide metabolism—ADSL—atopic dermatitis	0.00714	0.052	CbGpPWpGaD
Vidarabine—DPP4—Peptide hormone metabolism—CMA1—atopic dermatitis	0.00632	0.046	CbGpPWpGaD
Vidarabine—Glucosamine—TNF—atopic dermatitis	0.00574	0.295	CrCbGaD
Vidarabine—ADA—Circadian rythm related genes—RELB—atopic dermatitis	0.00542	0.0394	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—RELB—atopic dermatitis	0.00311	0.0227	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Other—CXCR3—atopic dermatitis	0.00204	0.0149	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—NPS—atopic dermatitis	0.00192	0.014	CbGpPWpGaD
Vidarabine—ADORA2A—Monoamine Transport—IL1B—atopic dermatitis	0.00171	0.0125	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00166	0.012	CbGpPWpGaD
Vidarabine—ADORA2A—G alpha (s) signalling events—NPS—atopic dermatitis	0.00163	0.0118	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—GLB1—atopic dermatitis	0.00157	0.0115	CbGpPWpGaD
Vidarabine—Convulsion—Tacrolimus—atopic dermatitis	0.00152	0.0018	CcSEcCtD
Vidarabine—Hypertension—Tacrolimus—atopic dermatitis	0.00151	0.00179	CcSEcCtD
Vidarabine—Asthenia—Loratadine—atopic dermatitis	0.0015	0.00178	CcSEcCtD
Vidarabine—ADA—C-MYB transcription factor network—CD4—atopic dermatitis	0.00149	0.0109	CbGpPWpGaD
Vidarabine—Chest pain—Tacrolimus—atopic dermatitis	0.00149	0.00177	CcSEcCtD
Vidarabine—Anxiety—Tacrolimus—atopic dermatitis	0.00148	0.00176	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00148	0.0107	CbGpPWpGaD
Vidarabine—Cardiac arrest—Dexamethasone—atopic dermatitis	0.00147	0.00175	CcSEcCtD
Vidarabine—Cardiac arrest—Betamethasone—atopic dermatitis	0.00147	0.00175	CcSEcCtD
Vidarabine—Discomfort—Tacrolimus—atopic dermatitis	0.00147	0.00175	CcSEcCtD
Vidarabine—Mood swings—Dexamethasone—atopic dermatitis	0.00147	0.00174	CcSEcCtD
Vidarabine—Mood swings—Betamethasone—atopic dermatitis	0.00147	0.00174	CcSEcCtD
Vidarabine—Dry mouth—Tacrolimus—atopic dermatitis	0.00146	0.00173	CcSEcCtD
Vidarabine—Bronchospasm—Methylprednisolone—atopic dermatitis	0.00145	0.00172	CcSEcCtD
Vidarabine—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.00143	0.00169	CcSEcCtD
Vidarabine—Acute coronary syndrome—Prednisolone—atopic dermatitis	0.00141	0.00167	CcSEcCtD
Vidarabine—Shock—Tacrolimus—atopic dermatitis	0.0014	0.00167	CcSEcCtD
Vidarabine—Myocardial infarction—Prednisolone—atopic dermatitis	0.0014	0.00166	CcSEcCtD
Vidarabine—Tachycardia—Tacrolimus—atopic dermatitis	0.00139	0.00165	CcSEcCtD
Vidarabine—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.00138	0.00164	CcSEcCtD
Vidarabine—Dizziness—Loratadine—atopic dermatitis	0.00138	0.00164	CcSEcCtD
Vidarabine—Cardiac failure—Prednisone—atopic dermatitis	0.00138	0.00164	CcSEcCtD
Vidarabine—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.00138	0.00164	CcSEcCtD
Vidarabine—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	0.00138	0.00163	CcSEcCtD
Vidarabine—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.00137	0.00162	CcSEcCtD
Vidarabine—Hypotension—Tacrolimus—atopic dermatitis	0.00133	0.00158	CcSEcCtD
Vidarabine—Vomiting—Loratadine—atopic dermatitis	0.00133	0.00158	CcSEcCtD
Vidarabine—Affect lability—Prednisone—atopic dermatitis	0.00133	0.00157	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00132	0.00963	CbGpPWpGaD
Vidarabine—Rash—Loratadine—atopic dermatitis	0.00132	0.00156	CcSEcCtD
Vidarabine—Dermatitis—Loratadine—atopic dermatitis	0.00132	0.00156	CcSEcCtD
Vidarabine—Headache—Loratadine—atopic dermatitis	0.00131	0.00155	CcSEcCtD
Vidarabine—Bradycardia—Prednisolone—atopic dermatitis	0.00131	0.00155	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.0013	0.00154	CcSEcCtD
Vidarabine—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.0013	0.00154	CcSEcCtD
Vidarabine—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.00129	0.00153	CcSEcCtD
Vidarabine—Myocardial infarction—Triamcinolone—atopic dermatitis	0.00129	0.00153	CcSEcCtD
Vidarabine—Asthenia—Mometasone—atopic dermatitis	0.00129	0.00153	CcSEcCtD
Vidarabine—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.00129	0.00153	CcSEcCtD
Vidarabine—Cardiac arrest—Prednisone—atopic dermatitis	0.00128	0.00152	CcSEcCtD
Vidarabine—Paraesthesia—Tacrolimus—atopic dermatitis	0.00128	0.00152	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Other—CCR5—atopic dermatitis	0.00128	0.00932	CbGpPWpGaD
Vidarabine—Mood swings—Prednisone—atopic dermatitis	0.00128	0.00152	CcSEcCtD
Vidarabine—Bradycardia—Hydrocortisone—atopic dermatitis	0.00128	0.00151	CcSEcCtD
Vidarabine—Dyspnoea—Tacrolimus—atopic dermatitis	0.00127	0.00151	CcSEcCtD
Vidarabine—Somnolence—Tacrolimus—atopic dermatitis	0.00127	0.00151	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CCL22—atopic dermatitis	0.00126	0.00917	CbGpPWpGaD
Vidarabine—Sweating—Methylprednisolone—atopic dermatitis	0.00126	0.00149	CcSEcCtD
Vidarabine—ADORA2A—Monoamine Transport—TNF—atopic dermatitis	0.00124	0.00905	CbGpPWpGaD
Vidarabine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00124	0.00147	CcSEcCtD
Vidarabine—Nausea—Loratadine—atopic dermatitis	0.00124	0.00147	CcSEcCtD
Vidarabine—Pain—Tacrolimus—atopic dermatitis	0.00122	0.00145	CcSEcCtD
Vidarabine—Bradycardia—Triamcinolone—atopic dermatitis	0.0012	0.00143	CcSEcCtD
Vidarabine—Bradycardia—Methylprednisolone—atopic dermatitis	0.0012	0.00142	CcSEcCtD
Vidarabine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00119	0.00142	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—CMA1—atopic dermatitis	0.00119	0.00868	CbGpPWpGaD
Vidarabine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.00118	0.00141	CcSEcCtD
Vidarabine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.00118	0.0014	CcSEcCtD
Vidarabine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.00118	0.0014	CcSEcCtD
Vidarabine—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.00118	0.0014	CcSEcCtD
Vidarabine—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.00118	0.0014	CcSEcCtD
Vidarabine—Myocardial infarction—Dexamethasone—atopic dermatitis	0.00117	0.00139	CcSEcCtD
Vidarabine—Myocardial infarction—Betamethasone—atopic dermatitis	0.00117	0.00139	CcSEcCtD
Vidarabine—Arrhythmia—Prednisolone—atopic dermatitis	0.00115	0.00136	CcSEcCtD
Vidarabine—Vomiting—Mometasone—atopic dermatitis	0.00114	0.00135	CcSEcCtD
Vidarabine—Urticaria—Tacrolimus—atopic dermatitis	0.00113	0.00135	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—PPARA—atopic dermatitis	0.00113	0.00825	CbGpPWpGaD
Vidarabine—Rash—Mometasone—atopic dermatitis	0.00113	0.00134	CcSEcCtD
Vidarabine—Dermatitis—Mometasone—atopic dermatitis	0.00113	0.00134	CcSEcCtD
Vidarabine—Headache—Mometasone—atopic dermatitis	0.00112	0.00133	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CCL27—atopic dermatitis	0.00112	0.00818	CbGpPWpGaD
Vidarabine—Arrhythmia—Hydrocortisone—atopic dermatitis	0.00112	0.00133	CcSEcCtD
Vidarabine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00112	0.00132	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—NPS—atopic dermatitis	0.0011	0.00804	CbGpPWpGaD
Vidarabine—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.00109	0.0013	CcSEcCtD
Vidarabine—Bradycardia—Dexamethasone—atopic dermatitis	0.00109	0.00129	CcSEcCtD
Vidarabine—Bradycardia—Betamethasone—atopic dermatitis	0.00109	0.00129	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00107	0.00776	CbGpPWpGaD
Vidarabine—Nausea—Mometasone—atopic dermatitis	0.00107	0.00126	CcSEcCtD
Vidarabine—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.00106	0.00126	CcSEcCtD
Vidarabine—Arrhythmia—Triamcinolone—atopic dermatitis	0.00105	0.00125	CcSEcCtD
Vidarabine—Vision blurred—Prednisolone—atopic dermatitis	0.00105	0.00125	CcSEcCtD
Vidarabine—Arrhythmia—Methylprednisolone—atopic dermatitis	0.00105	0.00125	CcSEcCtD
Vidarabine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.00105	0.00125	CcSEcCtD
Vidarabine—Asthenia—Tacrolimus—atopic dermatitis	0.00102	0.00122	CcSEcCtD
Vidarabine—Acute coronary syndrome—Prednisone—atopic dermatitis	0.00102	0.00121	CcSEcCtD
Vidarabine—Angioedema—Prednisolone—atopic dermatitis	0.00102	0.00121	CcSEcCtD
Vidarabine—Myocardial infarction—Prednisone—atopic dermatitis	0.00102	0.00121	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00102	0.00739	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCL17—atopic dermatitis	0.00101	0.00733	CbGpPWpGaD
Vidarabine—Dysgeusia—Triamcinolone—atopic dermatitis	0.00101	0.00119	CcSEcCtD
Vidarabine—Syncope—Prednisolone—atopic dermatitis	0.001	0.00119	CcSEcCtD
Vidarabine—Angioedema—Hydrocortisone—atopic dermatitis	0.000997	0.00118	CcSEcCtD
Vidarabine—ADK—Metabolism—GLB1—atopic dermatitis	0.000996	0.00724	CbGpPWpGaD
Vidarabine—Back pain—Triamcinolone—atopic dermatitis	0.000994	0.00118	CcSEcCtD
Vidarabine—Loss of consciousness—Prednisolone—atopic dermatitis	0.000982	0.00116	CcSEcCtD
Vidarabine—Syncope—Hydrocortisone—atopic dermatitis	0.000979	0.00116	CcSEcCtD
Vidarabine—Convulsion—Prednisolone—atopic dermatitis	0.000968	0.00115	CcSEcCtD
Vidarabine—Hypertension—Prednisolone—atopic dermatitis	0.000965	0.00114	CcSEcCtD
Vidarabine—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000959	0.00114	CcSEcCtD
Vidarabine—Arrhythmia—Dexamethasone—atopic dermatitis	0.000957	0.00113	CcSEcCtD
Vidarabine—Arrhythmia—Betamethasone—atopic dermatitis	0.000957	0.00113	CcSEcCtD
Vidarabine—ADK—Metabolism—ADSL—atopic dermatitis	0.000954	0.00694	CbGpPWpGaD
Vidarabine—Bradycardia—Prednisone—atopic dermatitis	0.00095	0.00113	CcSEcCtD
Vidarabine—Convulsion—Hydrocortisone—atopic dermatitis	0.000946	0.00112	CcSEcCtD
Vidarabine—Dizziness—Tacrolimus—atopic dermatitis	0.000944	0.00112	CcSEcCtD
Vidarabine—Hypertension—Hydrocortisone—atopic dermatitis	0.000942	0.00112	CcSEcCtD
Vidarabine—Discomfort—Prednisolone—atopic dermatitis	0.00094	0.00111	CcSEcCtD
Vidarabine—Angioedema—Triamcinolone—atopic dermatitis	0.000939	0.00111	CcSEcCtD
Vidarabine—Angioedema—Methylprednisolone—atopic dermatitis	0.000937	0.00111	CcSEcCtD
Vidarabine—Anxiety—Hydrocortisone—atopic dermatitis	0.000926	0.0011	CcSEcCtD
Vidarabine—Syncope—Triamcinolone—atopic dermatitis	0.000922	0.00109	CcSEcCtD
Vidarabine—Syncope—Methylprednisolone—atopic dermatitis	0.00092	0.00109	CcSEcCtD
Vidarabine—Discomfort—Hydrocortisone—atopic dermatitis	0.000918	0.00109	CcSEcCtD
Vidarabine—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000912	0.00108	CcSEcCtD
Vidarabine—Vomiting—Tacrolimus—atopic dermatitis	0.000908	0.00108	CcSEcCtD
Vidarabine—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000903	0.00107	CcSEcCtD
Vidarabine—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000901	0.00107	CcSEcCtD
Vidarabine—Rash—Tacrolimus—atopic dermatitis	0.0009	0.00107	CcSEcCtD
Vidarabine—Dermatitis—Tacrolimus—atopic dermatitis	0.000899	0.00107	CcSEcCtD
Vidarabine—Shock—Prednisolone—atopic dermatitis	0.000897	0.00106	CcSEcCtD
Vidarabine—Cough—Triamcinolone—atopic dermatitis	0.000897	0.00106	CcSEcCtD
Vidarabine—Headache—Tacrolimus—atopic dermatitis	0.000895	0.00106	CcSEcCtD
Vidarabine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000891	0.00106	CcSEcCtD
Vidarabine—Convulsion—Triamcinolone—atopic dermatitis	0.00089	0.00106	CcSEcCtD
Vidarabine—Tachycardia—Prednisolone—atopic dermatitis	0.00089	0.00106	CcSEcCtD
Vidarabine—Convulsion—Methylprednisolone—atopic dermatitis	0.000888	0.00105	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000887	0.00646	CbGpPWpGaD
Vidarabine—Hypertension—Triamcinolone—atopic dermatitis	0.000887	0.00105	CcSEcCtD
Vidarabine—Hypertension—Methylprednisolone—atopic dermatitis	0.000885	0.00105	CcSEcCtD
Vidarabine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000882	0.00105	CcSEcCtD
Vidarabine—Shock—Hydrocortisone—atopic dermatitis	0.000876	0.00104	CcSEcCtD
Vidarabine—Anxiety—Methylprednisolone—atopic dermatitis	0.00087	0.00103	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00087	0.00633	CbGpPWpGaD
Vidarabine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000869	0.00103	CcSEcCtD
Vidarabine—Flushing—Prednisone—atopic dermatitis	0.000866	0.00103	CcSEcCtD
Vidarabine—Discomfort—Triamcinolone—atopic dermatitis	0.000864	0.00103	CcSEcCtD
Vidarabine—Discomfort—Methylprednisolone—atopic dermatitis	0.000863	0.00102	CcSEcCtD
Vidarabine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000861	0.00102	CcSEcCtD
Vidarabine—Dry mouth—Triamcinolone—atopic dermatitis	0.000856	0.00101	CcSEcCtD
Vidarabine—Angioedema—Betamethasone—atopic dermatitis	0.000852	0.00101	CcSEcCtD
Vidarabine—Angioedema—Dexamethasone—atopic dermatitis	0.000852	0.00101	CcSEcCtD
Vidarabine—Nausea—Tacrolimus—atopic dermatitis	0.000848	0.00101	CcSEcCtD
Vidarabine—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000839	0.000995	CcSEcCtD
Vidarabine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000837	0.000993	CcSEcCtD
Vidarabine—Syncope—Dexamethasone—atopic dermatitis	0.000836	0.000992	CcSEcCtD
Vidarabine—Syncope—Betamethasone—atopic dermatitis	0.000836	0.000992	CcSEcCtD
Vidarabine—Arrhythmia—Prednisone—atopic dermatitis	0.000833	0.000988	CcSEcCtD
Vidarabine—Hypotension—Hydrocortisone—atopic dermatitis	0.000832	0.000987	CcSEcCtD
Vidarabine—Shock—Triamcinolone—atopic dermatitis	0.000825	0.000979	CcSEcCtD
Vidarabine—Shock—Methylprednisolone—atopic dermatitis	0.000823	0.000977	CcSEcCtD
Vidarabine—Loss of consciousness—Betamethasone—atopic dermatitis	0.00082	0.000972	CcSEcCtD
Vidarabine—Loss of consciousness—Dexamethasone—atopic dermatitis	0.00082	0.000972	CcSEcCtD
Vidarabine—Paraesthesia—Prednisolone—atopic dermatitis	0.000819	0.000971	CcSEcCtD
Vidarabine—Tachycardia—Triamcinolone—atopic dermatitis	0.000819	0.000971	CcSEcCtD
Vidarabine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000817	0.000969	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CCL11—atopic dermatitis	0.000812	0.00591	CbGpPWpGaD
Vidarabine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000812	0.000963	CcSEcCtD
Vidarabine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000811	0.000962	CcSEcCtD
Vidarabine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000809	0.00096	CcSEcCtD
Vidarabine—Convulsion—Betamethasone—atopic dermatitis	0.000808	0.000958	CcSEcCtD
Vidarabine—Convulsion—Dexamethasone—atopic dermatitis	0.000808	0.000958	CcSEcCtD
Vidarabine—Hypertension—Dexamethasone—atopic dermatitis	0.000805	0.000955	CcSEcCtD
Vidarabine—Hypertension—Betamethasone—atopic dermatitis	0.000805	0.000955	CcSEcCtD
Vidarabine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.0008	0.000949	CcSEcCtD
Vidarabine—Anxiety—Dexamethasone—atopic dermatitis	0.000791	0.000938	CcSEcCtD
Vidarabine—Anxiety—Betamethasone—atopic dermatitis	0.000791	0.000938	CcSEcCtD
Vidarabine—Discomfort—Betamethasone—atopic dermatitis	0.000784	0.00093	CcSEcCtD
Vidarabine—Discomfort—Dexamethasone—atopic dermatitis	0.000784	0.00093	CcSEcCtD
Vidarabine—Hypotension—Methylprednisolone—atopic dermatitis	0.000782	0.000927	CcSEcCtD
Vidarabine—Pain—Prednisolone—atopic dermatitis	0.00078	0.000925	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000775	0.00564	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000775	0.00564	CbGpPWpGaD
Vidarabine—Vision blurred—Prednisone—atopic dermatitis	0.000765	0.000908	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000764	0.000906	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000762	0.000904	CcSEcCtD
Vidarabine—Pain—Hydrocortisone—atopic dermatitis	0.000762	0.000903	CcSEcCtD
Vidarabine—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000761	0.000903	CcSEcCtD
Vidarabine—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000761	0.000903	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00076	0.00553	CbGpPWpGaD
Vidarabine—Paraesthesia—Triamcinolone—atopic dermatitis	0.000753	0.000893	CcSEcCtD
Vidarabine—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000751	0.000891	CcSEcCtD
Vidarabine—Shock—Dexamethasone—atopic dermatitis	0.000749	0.000888	CcSEcCtD
Vidarabine—Shock—Betamethasone—atopic dermatitis	0.000749	0.000888	CcSEcCtD
Vidarabine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000748	0.000887	CcSEcCtD
Vidarabine—Agitation—Prednisone—atopic dermatitis	0.000746	0.000885	CcSEcCtD
Vidarabine—Tachycardia—Betamethasone—atopic dermatitis	0.000743	0.000881	CcSEcCtD
Vidarabine—Tachycardia—Dexamethasone—atopic dermatitis	0.000743	0.000881	CcSEcCtD
Vidarabine—Angioedema—Prednisone—atopic dermatitis	0.000742	0.00088	CcSEcCtD
Vidarabine—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000736	0.000873	CcSEcCtD
Vidarabine—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000736	0.000873	CcSEcCtD
Vidarabine—Syncope—Prednisone—atopic dermatitis	0.000728	0.000864	CcSEcCtD
Vidarabine—Urticaria—Prednisolone—atopic dermatitis	0.000725	0.000859	CcSEcCtD
Vidarabine—Pain—Triamcinolone—atopic dermatitis	0.000717	0.000851	CcSEcCtD
Vidarabine—Loss of consciousness—Prednisone—atopic dermatitis	0.000714	0.000847	CcSEcCtD
Vidarabine—Hypotension—Dexamethasone—atopic dermatitis	0.000711	0.000843	CcSEcCtD
Vidarabine—Hypotension—Betamethasone—atopic dermatitis	0.000711	0.000843	CcSEcCtD
Vidarabine—Urticaria—Hydrocortisone—atopic dermatitis	0.000708	0.000839	CcSEcCtD
Vidarabine—Convulsion—Prednisone—atopic dermatitis	0.000704	0.000835	CcSEcCtD
Vidarabine—Hypertension—Prednisone—atopic dermatitis	0.000701	0.000832	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000693	0.000822	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000693	0.000822	CcSEcCtD
Vidarabine—Anxiety—Prednisone—atopic dermatitis	0.000689	0.000817	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NGF—atopic dermatitis	0.000685	0.00498	CbGpPWpGaD
Vidarabine—Paraesthesia—Dexamethasone—atopic dermatitis	0.000683	0.000811	CcSEcCtD
Vidarabine—Paraesthesia—Betamethasone—atopic dermatitis	0.000683	0.000811	CcSEcCtD
Vidarabine—Discomfort—Prednisone—atopic dermatitis	0.000683	0.00081	CcSEcCtD
Vidarabine—ADA—Metabolism—GLB1—atopic dermatitis	0.000677	0.00492	CbGpPWpGaD
Vidarabine—Hypersensitivity—Prednisolone—atopic dermatitis	0.000672	0.000797	CcSEcCtD
Vidarabine—Urticaria—Triamcinolone—atopic dermatitis	0.000666	0.00079	CcSEcCtD
Vidarabine—Urticaria—Methylprednisolone—atopic dermatitis	0.000665	0.000789	CcSEcCtD
Vidarabine—Anaphylactic shock—Prednisone—atopic dermatitis	0.000663	0.000786	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CCR3—atopic dermatitis	0.000662	0.00482	CbGpPWpGaD
Vidarabine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000656	0.000778	CcSEcCtD
Vidarabine—Shock—Prednisone—atopic dermatitis	0.000652	0.000773	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—PPARA—atopic dermatitis	0.000651	0.00474	CbGpPWpGaD
Vidarabine—Pain—Betamethasone—atopic dermatitis	0.000651	0.000772	CcSEcCtD
Vidarabine—Pain—Dexamethasone—atopic dermatitis	0.000651	0.000772	CcSEcCtD
Vidarabine—ADA—Metabolism—ADSL—atopic dermatitis	0.000649	0.00472	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL22—atopic dermatitis	0.000647	0.00471	CbGpPWpGaD
Vidarabine—Tachycardia—Prednisone—atopic dermatitis	0.000647	0.000767	CcSEcCtD
Vidarabine—Hyperhidrosis—Prednisone—atopic dermatitis	0.000641	0.00076	CcSEcCtD
Vidarabine—Asthenia—Hydrocortisone—atopic dermatitis	0.000639	0.000758	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—CCL27—atopic dermatitis	0.000635	0.00462	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—MAPK8—atopic dermatitis	0.000629	0.00458	CbGpPWpGaD
Vidarabine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000618	0.000733	CcSEcCtD
Vidarabine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000617	0.000731	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000614	0.00447	CbGpPWpGaD
Vidarabine—Urticaria—Betamethasone—atopic dermatitis	0.000605	0.000717	CcSEcCtD
Vidarabine—Urticaria—Dexamethasone—atopic dermatitis	0.000605	0.000717	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000604	0.000716	CcSEcCtD
Vidarabine—Dizziness—Prednisolone—atopic dermatitis	0.000603	0.000715	CcSEcCtD
Vidarabine—Asthenia—Triamcinolone—atopic dermatitis	0.000602	0.000714	CcSEcCtD
Vidarabine—Asthenia—Methylprednisolone—atopic dermatitis	0.0006	0.000712	CcSEcCtD
Vidarabine—Paraesthesia—Prednisone—atopic dermatitis	0.000595	0.000706	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—NPS—atopic dermatitis	0.00059	0.0043	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—TAC1—atopic dermatitis	0.00059	0.0043	CbGpPWpGaD
Vidarabine—Dizziness—Hydrocortisone—atopic dermatitis	0.000589	0.000699	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CXCR3—atopic dermatitis	0.000579	0.00421	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL27—atopic dermatitis	0.000577	0.0042	CbGpPWpGaD
Vidarabine—Rash—Prednisolone—atopic dermatitis	0.000575	0.000682	CcSEcCtD
Vidarabine—Dermatitis—Prednisolone—atopic dermatitis	0.000575	0.000681	CcSEcCtD
Vidarabine—Headache—Prednisolone—atopic dermatitis	0.000571	0.000678	CcSEcCtD
Vidarabine—Vomiting—Hydrocortisone—atopic dermatitis	0.000566	0.000672	CcSEcCtD
Vidarabine—Rash—Hydrocortisone—atopic dermatitis	0.000562	0.000666	CcSEcCtD
Vidarabine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000561	0.000666	CcSEcCtD
Vidarabine—Headache—Hydrocortisone—atopic dermatitis	0.000558	0.000662	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000556	0.00405	CbGpPWpGaD
Vidarabine—Dizziness—Triamcinolone—atopic dermatitis	0.000555	0.000658	CcSEcCtD
Vidarabine—Dizziness—Methylprednisolone—atopic dermatitis	0.000553	0.000656	CcSEcCtD
Vidarabine—Asthenia—Betamethasone—atopic dermatitis	0.000546	0.000648	CcSEcCtD
Vidarabine—Asthenia—Dexamethasone—atopic dermatitis	0.000546	0.000648	CcSEcCtD
Vidarabine—Nausea—Prednisolone—atopic dermatitis	0.000542	0.000643	CcSEcCtD
Vidarabine—Vomiting—Triamcinolone—atopic dermatitis	0.000533	0.000633	CcSEcCtD
Vidarabine—Vomiting—Methylprednisolone—atopic dermatitis	0.000532	0.000631	CcSEcCtD
Vidarabine—Nausea—Hydrocortisone—atopic dermatitis	0.000529	0.000628	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000529	0.00385	CbGpPWpGaD
Vidarabine—Rash—Triamcinolone—atopic dermatitis	0.000529	0.000627	CcSEcCtD
Vidarabine—Dermatitis—Triamcinolone—atopic dermatitis	0.000528	0.000627	CcSEcCtD
Vidarabine—Rash—Methylprednisolone—atopic dermatitis	0.000528	0.000626	CcSEcCtD
Vidarabine—Dermatitis—Methylprednisolone—atopic dermatitis	0.000527	0.000625	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—NGF—atopic dermatitis	0.000527	0.00383	CbGpPWpGaD
Vidarabine—Urticaria—Prednisone—atopic dermatitis	0.000527	0.000624	CcSEcCtD
Vidarabine—Headache—Triamcinolone—atopic dermatitis	0.000525	0.000623	CcSEcCtD
Vidarabine—Headache—Methylprednisolone—atopic dermatitis	0.000524	0.000622	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—CCL17—atopic dermatitis	0.000517	0.00376	CbGpPWpGaD
Vidarabine—Dizziness—Betamethasone—atopic dermatitis	0.000503	0.000597	CcSEcCtD
Vidarabine—Dizziness—Dexamethasone—atopic dermatitis	0.000503	0.000597	CcSEcCtD
Vidarabine—Nausea—Triamcinolone—atopic dermatitis	0.000498	0.000591	CcSEcCtD
Vidarabine—Nausea—Methylprednisolone—atopic dermatitis	0.000497	0.00059	CcSEcCtD
Vidarabine—Hypersensitivity—Prednisone—atopic dermatitis	0.000488	0.000579	CcSEcCtD
Vidarabine—Vomiting—Betamethasone—atopic dermatitis	0.000484	0.000574	CcSEcCtD
Vidarabine—Vomiting—Dexamethasone—atopic dermatitis	0.000484	0.000574	CcSEcCtD
Vidarabine—Rash—Dexamethasone—atopic dermatitis	0.00048	0.000569	CcSEcCtD
Vidarabine—Rash—Betamethasone—atopic dermatitis	0.00048	0.000569	CcSEcCtD
Vidarabine—Dermatitis—Betamethasone—atopic dermatitis	0.000479	0.000569	CcSEcCtD
Vidarabine—Dermatitis—Dexamethasone—atopic dermatitis	0.000479	0.000569	CcSEcCtD
Vidarabine—Headache—Betamethasone—atopic dermatitis	0.000477	0.000565	CcSEcCtD
Vidarabine—Headache—Dexamethasone—atopic dermatitis	0.000477	0.000565	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000477	0.00347	CbGpPWpGaD
Vidarabine—Asthenia—Prednisone—atopic dermatitis	0.000476	0.000564	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL10—atopic dermatitis	0.000468	0.0034	CbGpPWpGaD
Vidarabine—Nausea—Dexamethasone—atopic dermatitis	0.000452	0.000536	CcSEcCtD
Vidarabine—Nausea—Betamethasone—atopic dermatitis	0.000452	0.000536	CcSEcCtD
Vidarabine—Dizziness—Prednisone—atopic dermatitis	0.000438	0.00052	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—NFKBIA—atopic dermatitis	0.000434	0.00316	CbGpPWpGaD
Vidarabine—Vomiting—Prednisone—atopic dermatitis	0.000421	0.0005	CcSEcCtD
Vidarabine—Rash—Prednisone—atopic dermatitis	0.000418	0.000496	CcSEcCtD
Vidarabine—Dermatitis—Prednisone—atopic dermatitis	0.000417	0.000495	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—CCL11—atopic dermatitis	0.000417	0.00303	CbGpPWpGaD
Vidarabine—Headache—Prednisone—atopic dermatitis	0.000415	0.000492	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—FCER2—atopic dermatitis	0.000411	0.00299	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCL5—atopic dermatitis	0.000403	0.00293	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—IL6—atopic dermatitis	0.000402	0.00292	CbGpPWpGaD
Vidarabine—Nausea—Prednisone—atopic dermatitis	0.000394	0.000467	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—CCL22—atopic dermatitis	0.000382	0.00278	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR3—atopic dermatitis	0.000374	0.00272	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCR5—atopic dermatitis	0.000363	0.00264	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—MAPK8—atopic dermatitis	0.000361	0.00263	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL27—atopic dermatitis	0.000341	0.00248	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR3—atopic dermatitis	0.00034	0.00247	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—NPS—atopic dermatitis	0.000334	0.00243	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—TAC1—atopic dermatitis	0.000334	0.00243	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000327	0.00238	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PPARA—atopic dermatitis	0.000323	0.00235	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CXCL8—atopic dermatitis	0.000322	0.00234	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—IL5—atopic dermatitis	0.00031	0.00226	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL17—atopic dermatitis	0.000306	0.00222	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—NPS—atopic dermatitis	0.000303	0.0022	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—TAC1—atopic dermatitis	0.000303	0.0022	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCR3—atopic dermatitis	0.000297	0.00216	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000288	0.0021	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL5—atopic dermatitis	0.000282	0.00205	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAPK8—atopic dermatitis	0.000272	0.00198	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KIF3A—atopic dermatitis	0.000272	0.00198	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000264	0.00192	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CMA1—atopic dermatitis	0.000246	0.00179	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL11—atopic dermatitis	0.000246	0.00179	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL10—atopic dermatitis	0.00024	0.00175	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—STAT6—atopic dermatitis	0.000232	0.00168	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—IL6—atopic dermatitis	0.000231	0.00168	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCL5—atopic dermatitis	0.000228	0.00166	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	0.000226	0.00165	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARA—atopic dermatitis	0.00022	0.0016	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL8—atopic dermatitis	0.000219	0.0016	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL5—atopic dermatitis	0.000207	0.0015	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR5—atopic dermatitis	0.000205	0.00149	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR3—atopic dermatitis	0.000201	0.00146	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR5—atopic dermatitis	0.000186	0.00136	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TAC1—atopic dermatitis	0.000179	0.0013	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPS—atopic dermatitis	0.000179	0.0013	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCR3—atopic dermatitis	0.000175	0.00128	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6—atopic dermatitis	0.000174	0.00127	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL5—atopic dermatitis	0.000166	0.00121	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL10—atopic dermatitis	0.000142	0.00103	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000124	0.000902	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL5—atopic dermatitis	0.000122	0.000889	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—IL2—atopic dermatitis	0.000118	0.000862	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NGF—atopic dermatitis	0.000113	0.000823	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL8—atopic dermatitis	0.000113	0.000819	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR5—atopic dermatitis	0.00011	0.0008	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL2—atopic dermatitis	0.000108	0.000783	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NFKBIA—atopic dermatitis	9.33e-05	0.000679	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL8—atopic dermatitis	6.65e-05	0.000484	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL2—atopic dermatitis	6.36e-05	0.000462	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6—atopic dermatitis	6.32e-05	0.00046	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAPK8—atopic dermatitis	5.85e-05	0.000426	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6—atopic dermatitis	3.74e-05	0.000272	CbGpPWpGaD
